Total submissions: 9
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Genetic Services Laboratory, |
RCV000499446 | SCV000594279 | benign | not specified | 2018-02-15 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000550471 | SCV000634737 | benign | Warts, hypogammaglobulinemia, infections, and myelokathexis | 2024-01-31 | criteria provided, single submitter | clinical testing | |
Ce |
RCV001702665 | SCV002822687 | likely benign | not provided | 2024-02-01 | criteria provided, single submitter | clinical testing | CXCR4: BP4, BP7, BS1 |
ARUP Laboratories, |
RCV001702665 | SCV004564646 | benign | not provided | 2023-08-21 | criteria provided, single submitter | clinical testing | |
Breakthrough Genomics, |
RCV001702665 | SCV005245354 | benign | not provided | criteria provided, single submitter | not provided | ||
Laboratory of Diagnostic Genome Analysis, |
RCV000499446 | SCV001800376 | benign | not specified | no assertion criteria provided | clinical testing | ||
Genome Diagnostics Laboratory, |
RCV001702665 | SCV001930855 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV001702665 | SCV001966705 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Prevention |
RCV003925456 | SCV004746632 | likely benign | CXCR4-related disorder | 2019-09-06 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |